Clostridium difficile-associated diarrhea: Predictors of severity in patients presenting to the emergency department

Canadian Journal of Gastroenterology

Volumn 17, Issue 6, 2003, Pages 369-373

  Andrews, Christopher N ^a   Raboud, Janet ^a   Kassen, Barry O ^a   Enns, Robert ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antibiotics; Clostridium difficile; Diarrhea; Pseudomembranous colitis; Risk factors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTINEOPLASTIC AGENT; CEPHALOSPORIN DERIVATIVE; CISPLATIN; CLINDAMYCIN; CLOXACILLIN; ETOPOSIDE; MACROLIDE; MELPHALAN; METRONIDAZOLE; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFANILAMIDE; TETRACYCLINE; VANCOMYCIN;

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE; COLON RESECTION; COMMUNITY; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DISEASE CLASSIFICATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; GASTROINTESTINAL INFECTION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0042622674     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/723471     Document Type: Article

References (29)

1. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990;336:97-100.
2. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
3. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea: A review. Arch Intern Med 2001;161:525-33.
4. Anand A, Bashey B, Mir T, Glatt AE. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 1994;89:519-23.
5. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997;92:7,39-50.
6. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988;127:1289-94.
7. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
8. Cleary RK. Clostridium difficile-associated diarrhea and colitis: Clinical manifestations, diagnosis, and treatment. Dis Colon Rectum 1998;41:1435-49.
9. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999;20:43-50.
10. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678-84.
11. Ramaswamy R, Grover H, Corpuz M, Daniels P, Pitchumoni CS. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol 1996;91:460-4.
12. Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994;169:127-33.
13. Riley TV, Codde JP, Rouse IL. Increased length of hospital stay due to Clostridium difficile-associated diarrhoea. Lancet 1995;345:455-6.
14. Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis 1995;20(Suppl 2):S263-5.
15. Riley TV, O'Neill GL, Bowman RA, Golledge CL. Clostridium difficile-associated diarrhoea: Epidemiological data from Western Australia. Epidemiol Infect 1994;113:13-20.
16. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998;26:1027-34.
17. Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med 1992;117:297-302.
18. Stergachis A, Perera DR, Schnell MM, Jick H. Antibiotic-associated colitis. West J Med 1984;140:217-9.
19. Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C difficile Study Group. Clin Infect Dis 1998;26:141-5.
20. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: Evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166:561-7.
21. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981;143:42-50.
22. Alfa MJ, Kabani A, Lyerly D, et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000;38:2706-14.
23. Pituch H, van den Braak N, van Leeuwen W, et al. Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland. Clin Microbiol Infect 2001;7:442-6.
24. Marts BC, Longo WE, Vernava AM 3rd, Kennedy DJ, Daniel GL, Jones I. Patterns and prognosis of Clostridium difficile colitis. Dis Colon Rectum 1994;37:837-45.
25. Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991;118:633-7.
26. Mulligan ME, Miller SD, McFarland LV, Fung HC, Kwok RY. Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile. Clin Infect Dis 1993;16(Suppl 4):S239-44.
27. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME. Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997;24:324-33.
28. Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1985;80:867-8.
29. Clarke HJ, Jinnah RH, Byank RP, Cox QG. Clostridium difficile infection in orthopaedic patients. J Bone Joint Surg Am 1990;72:1056-9.